Mirae Asset Global Investments’s Vor Biopharma VOR Stock Holding History

Mirae Asset Global Investments’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$44.6K	Buy	2,423 +257	+12%	+$3.89K	﹤0.01%	1371
2026 Q1	$38.6K	Buy	2,166 +1,347	+164%	+$19K	﹤0.01%	1339
2025 Q4	$10.7K	Buy	+819	New	+$15.3K	﹤0.01%	1597
2023 Q3	–	Sell	-1,075	Closed	-$66.5K	–	2647
2023 Q2	$66.5K	Buy	+1,075	New	+$98.2K	﹤0.01%	2577

Other funds holding VOR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Mirae Asset Global Investments's VOR Position: Q2 2026 in Review

Mirae Asset Global Investments increased its Vor Biopharma (VOR) stake by 12% in Q2 2026, buying an estimated $3.89K and bringing the position to 2,423 shares worth $44.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1371.

Mirae Asset Global Investments first reported a position in VOR in Q2 2023 and has held it in 4 quarters since. The position peaked at $66.5K in Q2 2023. 25 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

Mirae Asset Global Investments held 2,423 shares of Vor Biopharma worth $44.6K as of Q2 2026.
Mirae Asset Global Investments bought 257 Vor Biopharma shares in Q2 2026, an estimated $3.89K.
Vor Biopharma made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1371 holding.
Mirae Asset Global Investments first reported a position in Vor Biopharma in Q2 2023 and has held it in 4 quarters since.
Mirae Asset Global Investments's Vor Biopharma position peaked at $66.5K in Q2 2023.
25 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.